ATE350026T1 - Erhaltung von körpereigenen proteinen - Google Patents
Erhaltung von körpereigenen proteinenInfo
- Publication number
- ATE350026T1 ATE350026T1 AT02716527T AT02716527T ATE350026T1 AT E350026 T1 ATE350026 T1 AT E350026T1 AT 02716527 T AT02716527 T AT 02716527T AT 02716527 T AT02716527 T AT 02716527T AT E350026 T1 ATE350026 T1 AT E350026T1
- Authority
- AT
- Austria
- Prior art keywords
- alpha
- skeletal muscle
- preserving
- kga
- ammonium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/773,394 US20020147237A1 (en) | 2001-01-31 | 2001-01-31 | Preservation of bodily protein |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE350026T1 true ATE350026T1 (de) | 2007-01-15 |
Family
ID=25098127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02716527T ATE350026T1 (de) | 2001-01-31 | 2002-01-28 | Erhaltung von körpereigenen proteinen |
Country Status (5)
Country | Link |
---|---|
US (1) | US20020147237A1 (de) |
EP (1) | EP1363615B1 (de) |
AT (1) | ATE350026T1 (de) |
DE (1) | DE60217302D1 (de) |
WO (1) | WO2002060429A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL368573A1 (en) * | 2004-06-17 | 2005-12-27 | Sgp & Sons Ab | Pharmaceutical compound influencing growth and mineralization processes in the axial and the appendicular skeleton as well as bone diseases of mature years among humans and animals as well as application of the pharmaceutical compound in the process of growth and mineralization of axial and appendicular skeleton and bone diseases of mature years among humans and animals |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987003806A1 (en) * | 1985-12-18 | 1987-07-02 | Veech Richard L | Parenteral nutrition therapy with amino acids |
SE8704217D0 (sv) * | 1987-10-29 | 1987-10-29 | Vinnars Erik Ab | Aminosyrakomposition for parenteral neringstillforsel |
SE462463B (sv) * | 1988-12-02 | 1990-07-02 | Decken Alexandra V D | Livs- och fodermedel innehaallande ketosyror |
US5219330A (en) * | 1991-11-26 | 1993-06-15 | Imed Corporation | Method and apparatus for preprogrammed infusion of iv medicaments |
SE9201584D0 (sv) * | 1992-05-20 | 1992-05-20 | Vinnars Erik Ab | Use of alpha-ketoglutarate |
JP3467290B2 (ja) * | 1993-08-12 | 2003-11-17 | 第一製網株式会社 | 養殖海苔の雑藻・病害駆除剤 |
-
2001
- 2001-01-31 US US09/773,394 patent/US20020147237A1/en not_active Abandoned
-
2002
- 2002-01-28 DE DE60217302T patent/DE60217302D1/de not_active Expired - Fee Related
- 2002-01-28 WO PCT/SE2002/000141 patent/WO2002060429A1/en active IP Right Grant
- 2002-01-28 EP EP02716527A patent/EP1363615B1/de not_active Expired - Lifetime
- 2002-01-28 AT AT02716527T patent/ATE350026T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60217302D1 (de) | 2007-02-15 |
EP1363615B1 (de) | 2007-01-03 |
US20020147237A1 (en) | 2002-10-10 |
EP1363615A1 (de) | 2003-11-26 |
WO2002060429A1 (en) | 2002-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT88985A (pt) | Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina | |
FI920026A0 (fi) | Farmaceutisk komposition anvaendbar som avmagringsmedicin. | |
RU94027680A (ru) | Паращитовидный гормон и ралоксифон для увеличения массы кости, фармацевтический состав и способ увеличения костной массы | |
MD1699F2 (ro) | Compoziţie apoasă a hormonului somatotrop uman şi procedeu de prevenire a denaturării ei | |
ATE113834T1 (de) | Zusammensetzung zur behandlung der schizophrenie. | |
IL152659A (en) | Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer | |
SE8504945L (sv) | Farmaceutiska kompositioner innehallande antracyklinglykosider | |
EA199900499A1 (ru) | Фармацевтическая композиция, включающая соединение, обладающее анти-xa активностью, и соединение антагонист агрегации тромбоцитов | |
ES2160643T3 (es) | Composiciones que contienen g-csf y proteina de union al tnf. | |
DE69120287D1 (en) | Aminosulfonylharnstoff-acat-inhibitoren | |
CA2060560A1 (en) | Method for insuring adequate intracellular glutathione in tissue | |
HUP9802897A3 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
CA2420640A1 (en) | Combination preparations of 3-n-formyl hydroxy amino propyl phosphonic acid derivatives or 3-n-acetyl hydroxy amino propyl phosphonic acid derivatives together with special pharmaceutical active ingredients | |
ATE350026T1 (de) | Erhaltung von körpereigenen proteinen | |
EP0373771A3 (de) | Neue pharmazeutische Anwendungen von Cystatinen | |
HUP9902415A2 (hu) | Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására | |
ATE401394T1 (de) | Verbesserte dnase flüssige lösungen | |
EA199700150A1 (ru) | КОМБИНИРОВАННОЕ ЛЕЧЕНИЕ ПО ПОВОДУ ВИЧ ИНФЕКЦИИ С ИСПОЛЬЗОВАНИЕМ ИНГИБИТОРА ПРОТЕАЗЫ ВИЧ ИНДИНАВИРА И ИНГИБИТОРА ОБРАТНОЙ ТРАНСКРИПТАЗЫ 3TC, НЕОБЯЗАТЕЛЬНО СОВМЕСТНО С AZT, ddI ИЛИ ddC | |
IE840977L (en) | Pharmaceutical preparations | |
DE69729201T2 (de) | Sulfonfluoride zur behandlung von der alzheimerischen krankheit | |
UA41326C2 (uk) | Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань | |
RU95105249A (ru) | Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения | |
WO2001028578A3 (en) | A PHARMACEUTICAL COMPOSITION CONTAINING pGLU-GLU-PRO-NH2 AND METHOD FOR TREATING DISEASES AND INJURIES TO THE BRAIN, SPINAL CORD AND RETINA USING SAME | |
KR950704358A (ko) | 카텝신 l 특이적 저해 폴리펩티드 | |
IT8348383A0 (it) | Enzima simile a pepsina da leucocito umano, procedimento per prepararlo, e composizione terapeutica che lo contiene come ingrediente attivo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |